Effective Drug Delivery System for Duchenne Muscular Dystrophy Using Hybrid Liposomes Including Gentamicin Along With Reduced Toxicity

Biological and Pharmaceutical Bulletin - Japan
doi 10.1248/bpb.34.712
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

Duchenne Muscular Dystrophy

Physiotherapy
Physical TherapySports TherapyRehabilitation
1990English

Duchenne Muscular Dystrophy

English

Duchenne Muscular Dystrophy

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Duchenne Muscular Dystrophy

2020English

150. Ex Vivo Gene Therapy of Duchenne Muscular Dystrophy Using iPSCs From Duchenne Muscular Dystrophy Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Emerging Drugs for Duchenne Muscular Dystrophy

Expert Opinion on Emerging Drugs
Pharmacology
2012English

Gene Therapy for Duchenne Muscular Dystrophy

Archives of Neurology
2007English

Echinocytes in Families With Duchenne Muscular Dystrophy.

Journal of Medical Genetics
Genetics
1977English

Teaching an Old Molecule New Tricks: Drug Repositioning for Duchenne Muscular Dystrophy

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy